Technique of Transcatheter Aortic Valve Implantation with the Edwards-Sapien® Heart Valve Using the Transfemoral Approach

被引:34
作者
Cribier, Alain [1 ,2 ]
Litzler, Pierre-Yves [3 ,4 ]
Eltchaninoff, Helene [1 ,2 ]
Godin, Matthieu [1 ,2 ]
Tron, Christophe [1 ,2 ]
Bauer, Fabrice [1 ,2 ]
Bessou, Jean-Paul [3 ,4 ]
机构
[1] Univ Rouen, Dept Cardiol, Hosp Charles Nicolle, F-76000 Rouen, France
[2] INSERM 144, F-76000 Rouen, France
[3] INSERM 644, Paris, France
[4] Univ Rouen, Dept Cardiothorac Surg, Hosp Charles Nicolle, F-76000 Rouen, France
关键词
Aortic valve stenosis; Valve replacement; Valve implantation; Prosthetic valves; STENOSIS; REPLACEMENT; PROSTHESIS;
D O I
10.1007/s00059-009-3264-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transcatheter aortic valve implantation (TAVI) using a balloon-expandable valve has been developed by the authors' group 7 years ago to offer a therapeutic solution to nonoperable or surgical high-risk patients with degenerative aortic stenosis. The technique and the devices used have rapidly evolved thereafter and TAVI has become a clinical reality with more than 3,500 patients implanted worldwide with this device. The currently used Edwards-Sapien (R) Transcatheter Heart Valve (THV) consists of a balloon-expandable stent with an integrated bovine pericardial valve. It can be implanted within the diseased native aortic valve using either the retrograde transfemoral or antegrade transapical routes. This article is aimed at describing the updated transfemoral technique. Appropriate patient selection is crucial for a successful procedure including close evaluation of the arterial characteristics. After predilatation of the native valve with a balloon catheter, the THV with its delivery system is introduced within the femoral artery, advanced to the native aortic valve under X-ray control, positioned across the aortic annulus, and delivered by balloon inflation under rapid heart pacing. The acute procedural success is 96% and the technique leads to an immediate and lasting improvement of hemodynamics and clinical status. Complications are rare and the mortality rate is 6.3% at 1 month in this cohort of very sick patients. Procedural complications are headed by vascular injury related to the large size of the arterial introducers. An upcoming lower-profile Edwards THV should improve this issue and increase the indication for this less invasive approach in the near future. At the present time, the indications should be restricted to nonoperable or surgical high-risk patients and the procedure performed by experienced and formally trained physicians working in an optimal multidisciplinary environment.
引用
收藏
页码:347 / 356
页数:10
相关论文
共 14 条
[1]  
Agatiello C, 2006, ARCH MAL COEUR VAISS, V99, P195
[2]   Percutaneous transcatheter aortic valve implantation: Evolution of the technology [J].
Chiam, Paul T. L. ;
Ruiz, Carlos E. .
AMERICAN HEART JOURNAL, 2009, 157 (02) :229-242
[3]   Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis [J].
Cribier, A ;
Eltchaninoff, H ;
Tron, C ;
Bauer, F ;
Agatiello, C ;
Sebagh, L ;
Bash, A ;
Nusimovici, D ;
Litzler, PY ;
Bessou, JP ;
Leon, MB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) :698-703
[4]   Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis - First human case description [J].
Cribier, A ;
Eltchaninoff, H ;
Bash, A ;
Borenstein, N ;
Tron, C ;
Bauer, F ;
Derumeaux, G ;
Anselme, F ;
Laborde, F ;
Leon, MB .
CIRCULATION, 2002, 106 (24) :3006-3008
[5]   Treatment of calcific aortic stenosis with the percutaneous heart valve - Mid-term follow-up from the initial feasibility studies: The French experience [J].
Cribier, A ;
Eltchaninoff, H ;
Tron, C ;
Bauer, F ;
Agatiello, C ;
Nercolini, D ;
Tapiero, S ;
Litzler, PY ;
Bessou, JP ;
Babaliaros, V .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (06) :1214-1223
[6]  
Solomon L W, 2001, J Invasive Cardiol, V13, P592
[7]  
*TASKF MAN VALV HE, 2007, EUR HEART J, V428, P1
[8]   Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI) [J].
Vahanian, Alec ;
Alfieri, Ottavio R. ;
At-Attar, Nawwar ;
Antunes, Manuel J. ;
Bax, Jeroen ;
Cormier, Bertrand ;
Cribier, Alain ;
De Jaegere, Peter ;
Fournial, Gerard ;
Kappetein, Arie Pieter ;
Kovac, Jan ;
Ludgate, Susanne ;
Maisano, Francesco ;
Moat, Neil ;
Mohr, Friedrich -Wihelm ;
Nataf, Patrick ;
Pierard, Luc ;
Pomar, Jose Luis ;
Schofer, Joachim ;
Tornos, Pilar ;
Tuzcu, Murat ;
van Hout, Ben ;
von Segesser, Ludwig K. ;
Walther, Thomas .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 34 (01) :1-8
[9]   Transapical minimally invasive aortic valve implantation - Multicenter experience [J].
Walther, Thomas ;
Simon, Paul ;
Dewey, Todd ;
Wimmer-Greinecker, Gerhard ;
Falk, Volkmar ;
Kasimir, Marie T. ;
Doss, Mirko ;
Borger, Michael A. ;
Schuler, Gerhard ;
Glogar, Dietmar ;
Fehske, Wolfgang ;
Wolner, Ernst ;
Mohr, Friedrich W. ;
Mack, Michael .
CIRCULATION, 2007, 116 (11) :I240-I245
[10]   Transapical Aortic Valve Implantation: Step by Step [J].
Walther, Thomas ;
Dewey, Todd ;
Borger, Michael A. ;
Kempfert, Joerg ;
Linke, Axel ;
Becht, Reinhardt ;
Falk, Volkmar ;
Schuler, Gerhard ;
Mohr, Friedrich W. ;
Mack, Michael .
ANNALS OF THORACIC SURGERY, 2009, 87 (01) :276-283